Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients
- 26 June 2001
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (12) , 1749-1751
- https://doi.org/10.1212/wnl.56.12.1749
Abstract
Deficient orexin signaling has been shown to cause narcolepsy-like conditions in animals. In human narcolepsy, CSF levels of orexin A (hypocretin-1) were reported to be low in most cases. The authors measured CSF and plasma orexin A levels in patients with narcolepsy and in controls. Confirming earlier studies, they found CSF orexin A levels to be extremely low in patients with narcolepsy. However, plasma orexin A levels did not differ from those observed in controls. These results suggest that orexin deficiency in patients with narcolepsy is a phenomena restricted to the CNS.Keywords
This publication has 8 references indexed in Scilit:
- Reduced Number of Hypocretin Neurons in Human NarcolepsyNeuron, 2004
- A prepro-orexin gene polymorphism is associated with narcolepsyNeurology, 2001
- A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsNature Medicine, 2000
- The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disordersTrends in Neurosciences, 2000
- Hypocretin (orexin) deficiency in human narcolepsyThe Lancet, 2000
- Orexin Synthesis and Response in the GutNeuron, 1999
- In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controlsNeurology, 1998
- Narcolepsy and immunityAdvances in Neuroimmunology, 1995